Intrinsic Value of S&P & Nasdaq Contact Us

National Research Corporation NRC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
$53.87
+216.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

National Research Corporation (NRC) trades at a trailing P/E of 31.9, forward P/E of 19.4. Trailing earnings yield is 3.13%, forward earnings yield 5.17%. PEG 0.28 (Peter Lynch undervalued ≤1.0). Graham Number is $2.77.

Criteria proven by this page:

  • VALUE (73/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.28).
  • Forward P/E 19.4 (down from trailing 31.9) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.28 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 3.13% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.17% as earnings recover.

Overall SharesGrow Score: 47/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
49/100
SG Score
View full scorecard →
VALUE
73/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
100/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
MOAT
43/100
→ Income
GROWTH
15/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — NRC

Valuation Multiples
P/E (TTM)31.9
Forward P/E19.4
PEG Ratio0.28
Forward PEG0.28
P/B Ratio26.47
P/S Ratio2.81
EV/EBITDA15.3
Per Share Data
EPS (TTM)$0.53
Forward EPS (Est.)$0.88
Book Value / Share$0.64
Revenue / Share$6.31
FCF / Share$0.72
Yields & Fair Value
Earnings Yield3.13%
Forward Earnings Yield5.17%
Dividend Yield3.29%
Graham Number$2.77
SharesGrow IV$53.87 (+216.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 22.4 1.35 5.56 4.21 6.21%
2017 39.5 3.87 10.06 7.71 1.86%
2018 34.4 0.33 54.14 8.63 1.63%
2019 50.5 2.95 49.74 12.78 1.91%
2020 28.9 2.09 16.73 8.07 0.98%
2021 28.2 -41.70 12.37 7.13 0.87%
2022 29.2 -2.26 12.91 6.13 2.25%
2023 31.3 -20.06 19.83 6.53 3.75%
2024 16.9 -1.01 13.38 2.92 2.74%
2025 36.2 -0.72 30.03 3.06 2.61%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.48 $109.38M $20.52M 18.8%
2017 $0.52 $117.56M $22.94M 19.5%
2018 $1.07 $119.69M $30.05M 25.1%
2019 $1.26 $127.98M $32.41M 25.3%
2020 $1.45 $133.28M $37.26M 28%
2021 $1.46 $147.95M $37.47M 25.3%
2022 $1.27 $151.57M $31.8M 21%
2023 $1.25 $148.58M $30.97M 20.8%
2024 $1.04 $143.06M $24.78M 17.3%
2025 $0.52 $137.39M $11.6M 8.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.88 $0.88 – $0.88 $118.3M $118.3M – $118.3M 1
2027 $1.11 $1.11 – $1.11 $127M $127M – $127M 1
2028 $1.16 $1.16 – $1.16 $129.3M $129.3M – $129.3M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message